| Citation: |
HU Yuqian, ZHENG Yi, NING Yong, XI Juan, XIE Shenggao. Epigenetic Mechanism of DNA Virus-mediated Carcinogenesis[J]. Cancer Research on Prevention and Treatment, 2016, 43(3): 230-233. DOI: 10.3971/j.issn.1000-8578.2016.03.013
|
| [1] |
D'Costa ZJ, Jolly C, Androphy EJ, et al. Transcriptional repression of E-cadherin by human papillomavirus type 16 E6[J]. PLoS One, 20 12, 7(11): e48954.
|
| [2] |
Gorres KL, Daigle D, Mohanram S, et al. Activation and repression of Epstein-Barr Virus and Kaposi’s sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids[J]. J Virol, 2014, 88(14): 8028-44.
|
| [3] |
McLaughlin-Drubin ME, Crum CP, Münger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming[J]. Proc Natl Acad Sci U S A, 2011, 108(5): 21 30-5.
|
| [4] |
Zhang X, Hou J, Lu M. Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs[J]. Front Genet, 2013, 4: 202.
|
| [5] |
Boosani CS, Agrawal DK. Methylation and microRNA-mediated epigenetic regulation of SOCS3[J]. Mol Biol Rep, 2015, 42(4): 85 3-72.
|
| [6] |
Tarocchi M, Polvani S, Marroncini G, et al. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis[J]. World J Gastroenterol, 2014, 20(33): 11630-40.
|
| [7] |
Fernandez AF, Esteller M. Viral epigenomes in human tumorigenesis[J]. Oncogene, 2010, 29(10): 1405-20.
|
| [8] |
Clarke MA, Wentzensen N, Mirabello L, et al. Human papillomavirus DNA methylation as a potential biomarker for cervical cancer[J]. Cancer Epidemiol Biomarkers Prev, 2012, 21 (12): 2125-37.
|
| [9] |
Fang J, Zhang H, Jin S. Epigenetics and cervical cancer: from pathogenesis to therapy[J]. Tumour Biol, 2014, 35(6): 5083-93.
|
| [10] |
Trietsch MD, Nooij LS, Gaarenstroom KN, et al. Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: a review of the current literature[J]. Gynecol Oncol, 2015, 136(1): 143-57.
|
| [11] |
Yang HJ. Aberrant DNA methylation in cervical carcinogenesis[J]. Chin J Cancer, 2013, 32(1): 42-8.
|
| [12] |
McLaughlin-Drubin ME, Crum CP, Münger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming[J]. Proc Natl Acad Sci U S A, 2011, 108(5): 21 30-5.
|
| [13] |
Pannone G, Zamparese R, Pace M, et al. The role of EBV in the pathogenesis of Burkitt's Lymphoma: an Italian hospital based survey[J]. Infect Agent Cancer, 2014, 9(1): 34.
|
| [14] |
Yip TT, Ngan RK, Fong AH, et al. Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma[J]. Oral Oncol, 2014, 50(6): 527-38.
|
| [15] |
Niller HH, Tarnai Z, Decsi G, et al. Role of epigenetics in EBV regulation and pathogenesis[J]. Future Microbiol, 2014, 9(6): 74 7-56.
|
| [16] |
Kim do N, Song YJ, Lee SK. The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines[J]. Exp Mol Med, 2011, 43(7): 401-10.
|
| [17] |
Lee H, Seo SY, Tiwari I, et al. Epstein-Barr Virus latent membrane protein 1 overcomes all-trans retinoic acid-induced apoptosis by inhibiting retinoic acid receptor-β60 expression[J]. Biochem Biophys Res Commun, 2012, 423(2): 313-8.
|
| [18] |
Tempera I, Lieberman PM. Epigenetic regulation of EBV persistence and oncogenesis[J]. Semin Cancer Biol, 2014, 26: 22-9.
|
| [19] |
Zhao C, Bu X. Promoter methylation of tumor-related genes in gastric carcinogenesis[J]. Histol Histopathol, 2012, 27(10): 12 71-82.
|
| [20] |
Anderton JA, Bose S, Vockerodt M, et al. The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and overexpressed in Hodgkin’s Lymphoma[J]. Oncogene, 2011, 30(17): 20 37-43.
|
| [21] |
Chen HS, Lu F, Lieberman PM. Epigenetic regulation of EBV and KSHV latency[J]. Curr Opin Virol, 2013, 3(3): 251-9.
|
| [22] |
Campbell M, Kung HJ, Izumiya Y. Long non-coding RNA and epigenetic gene regulation of KSHV[J]. Viruses, 2014, 6(11): 41 65-77.
|
| [23] |
Zhang YQ, Guo JS. Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma[J]. World J Gastroenterol, 2015, 21(13): 38 60-6.
|
| [24] |
Zhu R, Zhang JS, Zhu YZ, et al. HBx-induced androgen receptor expression in HBV-associated hepatocarcinoma is independent of the methylation status of its promoter[J]. Histol Histopathol, 2011, 26 (1): 23-35.
|
| [25] |
Xirong L, Rui L, Xiaoli Y, et al. Hepatitis B virus can be inhibited by DNA methyltransferase 3a via specific zinc-finger-induced methylation of the X promoter[J]. Biochemistry(Mosc), 2014, 79 (2): 111-23.
|
| [26] |
Rongrui L, Na H, Zongfang L, et al. Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis[J]. Curr Pharm Des, 2014, 20(11): 1715-25.
|
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: